A new study by researchers at Carnegie Mellon University highlights a critical gap in opioid research.
The study found that while the number of users is tracked, the intensity of use often goes unnoticed. The study says when drugs are more available and cheaper—especially potent ones like fentanyl—users tend to take higher doses more often, increasing risk.
The commonwealth has one of the highest per capita rates of opioid use disorder at over 2.5%. Between 2023 and 2024, the Attorney General’s office seized three million doses of fentanyl and 50,000 fentanyl pills. The state is using funds from pharmaceutical settlements to support prevention and treatment efforts in its fight against the epidemic.
Comments